OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Halozyme Therapeutics/  US40637H1095  /

IEX
2024-05-13  9:59:59 PM Chg. +0.49 Volume Bid- Ask- High Low
43.63USD +1.14% 45,450
Turnover: 1.98 mill.		 -Bid Size: - -Ask Size: - 44.02 43.38
GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02-14 Genmab Publishes 2023 Annual Report
GlobeNewswire 2023-11-06 Acumen Pharmaceuticals, Inc. and Halozyme Enter Global Collaboration and License Agreement to Develo...
GlobeNewswire 2022-02-22 Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
GlobeNewswire 2022-02-16 Genmab Publishes 2021 Annual Report
GlobeNewswire 2021-12-16 Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary
GlobeNewswire 2021-12-15 Surface Oncology Appoints Denice Torres as Chair of the Board of Directors
GlobeNewswire 2021-09-02 Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Off...
GlobeNewswire 2021-06-30 TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Progra...
GlobeNewswire 2021-05-26 Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors
GlobeNewswire 2021-05-12 Medicenna Appoints Immuno-Oncology Expert Dr. Mann Muhsin as Chief Medical Officer
GlobeNewswire 2021-03-15 Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer
GlobeNewswire 2021-03-01 Cerecor Appoints Schond L. Greenway as Chief Financial Officer
GlobeNewswire 2020-09-22 Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
GlobeNewswire 2020-03-05 Passage Bio Appoints Athena Countouriotis to Board of Directors
GlobeNewswire 2019-11-12 Bernadette Connaughton Appointed to Syneos Health Board of Directors
GlobeNewswire 2019-07-02 Madrigal Pharmaceuticals Announces Appointment of Jim Daly to Board of Directors
GlobeNewswire 2019-06-11 Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors
GlobeNewswire 2019-02-28 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
GlobeNewswire 2019-02-15 Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Car...
GlobeNewswire 2019-02-04 argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology
GlobeNewswire 2018-12-27 Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor ...
GlobeNewswire 2018-12-11 Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments
GlobeNewswire 2018-12-04 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therape...
GlobeNewswire 2018-12-03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therap...